Drug
Nerandomilast (Jascayd)
Status:
To Patients
Condition:
Idiopathic Pulmonary Fibrosis
Intervention Type:
Oral Drug
Funder Type:
Industry
Drug Detail
Nerandomilast (Jascayd) is an oral, phosphodiesterase 4B (PDE4B) inhibitor with combined antifibrotic and anti-inflammatory effects.